Skip to main content
Journal ArticleOPEN ACCESS

In vitro susceptibility to closthioamide among clinical and reference strains of Neisseria gonorrhoeae

Antimicrobial Agents and Chemotherapy (2017) 61(10)
DOI: 10.1128/AAC.00929-17
6Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Neisseria gonorrhoeae is one of the leading antimicrobial resistance threats worldwide. This study determined the MICs of closthioamide to be 0.008 to 0.5 mg/liter for clinical N. gonorrhoeae strains and related species. Cross-resistance with existing antimicrobial resistance was not detected, indicating that closthioamide could be used to treat drug-resistant N. gonorrhoeae.

Author supplied keywords

Cite

CITATION STYLE

APA

Miari, V. F., Solanki, P., Hleba, Y., Stabler, R. A., & Heap, J. T. (2017). In vitro susceptibility to closthioamide among clinical and reference strains of Neisseria gonorrhoeae. Antimicrobial Agents and Chemotherapy, 61(10). https://doi.org/10.1128/AAC.00929-17

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free